Infection of Inbred BALB/c and C57BL/6 and Outbred Institute of Cancer Research Mice with the Emerging H7N9 Avian Influenza Virus
Overview
Authors
Affiliations
A new avian-origin influenza virus A (H7N9) recently crossed the species barrier and infected humans; therefore, there is an urgent need to establish mammalian animal models for studying the pathogenic mechanism of this strain and the immunological response. In this study, we attempted to develop mouse models of H7N9 infection because mice are traditionally the most convenient models for studying influenza viruses. We showed that the novel A (H7N9) virus isolated from a patient could infect inbred BALB/c and C57BL/6 mice as well as outbred Institute of Cancer Research (ICR) mice. The amount of bodyweight lost showed differences at 7 days post infection (d.p.i.) (BALB/c mice 30%, C57BL/6 and ICR mice approximately 20%), and the lung indexes were increased both at 3 d.p.i. and at 7 d.p.i.. Immunohistochemistry demonstrated the existence of the H7N9 viruses in the lungs of the infected mice, and these findings were verified by quantitative real-time polymerase chain reaction (RT-PCR) and 50% tissue culture infectious dose (TCID50) detection at 3 d.p.i. and 7 d.p.i.. Histopathological changes occurred in the infected lungs, including pulmonary interstitial inflammatory lesions, pulmonary oedema and haemorrhages. Furthermore, because the most clinically severe cases were in elderly patients, we analysed the H7N9 infections in both young and old ICR mice. The old ICR mice showed more severe infections with more bodyweight lost and a higher lung index than the young ICR mice. Compared with the young ICR mice, the old mice showed a delayed clearance of the H7N9 virus and higher inflammation in the lungs. Thus, old ICR mice could partially mimic the more severe illness in elderly patients.
Jin X, Yang H, Zhao G, Dai C, Zhang Z, Zhou D Virol J. 2024; 21(1):240.
PMID: 39354538 PMC: 11446018. DOI: 10.1186/s12985-024-02516-6.
Xie X, Zhao C, He Q, Qiu T, Yuan S, Ding L Front Microbiol. 2019; 10:1630.
PMID: 31379782 PMC: 6647892. DOI: 10.3389/fmicb.2019.01630.
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells.
Park H, Tan P, Kavishna R, Ker A, Lu J, Chan C NPJ Vaccines. 2017; 2:31.
PMID: 29263886 PMC: 5674066. DOI: 10.1038/s41541-017-0033-5.
Ren R, Wu S, Cai J, Yang Y, Ren X, Feng Y Sci Rep. 2017; 7(1):7625.
PMID: 28790324 PMC: 5548739. DOI: 10.1038/s41598-017-07384-5.
NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.
Bar-On Y, Charpak-Amikam Y, Glasner A, Isaacson B, Duev-Cohen A, Tsukerman P J Virol. 2017; 91(19).
PMID: 28724773 PMC: 5599737. DOI: 10.1128/JVI.01045-17.